Eli Lilly and Company (NYSE: LLY) Q4 2025 earnings call transcript

Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings Call Transcript February 4, 2026 Eli Lilly and Company beats earnings ...
Hosted on MSN

Lilly to seek Jaypirca label expansion for first-line CLL/SLL usage

Eli Lilly is seeking a label expansion for earlier use of Jaypirca (pirtobrutinib) in treatment-naïve patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL) after it ...
SiliconANGLE

Nvidia, Lilly to invest up to $1B in new AI medical research lab

Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...
Nasdaq

Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral ...

Lilly's tirzepatide challenges semaglutide in obesity drug market

The trial enrolled 751 adults with obesity or overweight conditions and at least one weight-related medical problem ...